4th European Biopharma Congress
Biopharmaceuticals Conference SeriesConference Series has been instrumental in conducting international Biopharmaceuticals meetings for several years, and very excited to expand Europe, America and Asia Pacific continents. Previous meetings were held in major cities like San Francisco, Baltimore, with success the meetings again scheduled in continents. 4th European Biopharma Congress, is scheduled to be held during November 09-11, 2017; at Vienna, Austria.
The opportunity in biopharmaceuticals is big and growing too rapidly to ignore. Today, biopharmaceuticals generate global revenues of $163 billion, making up about 20%of the pharma market. It’s by far the fastest-growing part of the industry: biopharma’s current annual growth rate of more than 8% is double that of conventional pharma, and growth is expected to continue at that rate for the foreseeable future.
The world of Big Pharma is not only growing, it's standing on its head. Worldwide spending for prescription branded drugs and generic medicines will jump 30% from 2013-2018 at compound annual growth rate of over 5% leading to a jaw-dropping $1.3 trillion in annual global drug sales. The market is also radically shifting position, with traditional strongholds, such as Japan and Europe, flipping over, and emerging markets, such as China, becoming the head
"Major proponents of business- or image-based definitions refuse to recognize biopharmaceuticals as a subset of pharmaceuticals, preferring to lump together and use the term to apply to all pharmaceuticals, associated R&D, companies and industry" says Ronald A Rader from nature biotechnology, Nature Publishing Group
I hope this message finds you well. I'm honored to request your participation as a speaker/delegate at “4th European Biopharma Congress” during November 9-11, 2017 at Vienna, Austria. Euro Biopharma 2017 is a three day event with an audience from various areas of Pharma and Biopharma assembling experts from Academy and Research-Professors, Assistant Professors, PhD Scholars, Pharmaceutical Associations and Societies, Pharmaceutical Business Entrepreneurs, Pharmaceutical Manufacturing Companies, Medical Devices Manufacturing Companies, Directors, CEO’s of Organizations, CROs and Clinical Data Management Companies.
Our aim is to bring together bright minds to give talks that are idea-focused, and on a wide range of subjects, to foster learning, inspiration and provoke conversations that matter.
Website: Biopharma Conferences
Benefits of speaker:
• Keynote sessions by world’s most eminent researchers.
• Networking with Experts in the field
• Being a part of global forum of Biopharma professionals
• Upon acceptance the abstract will receive DOI from CrossRef and published in conference proceedings book.
• Top Industry Representation by mostly C-level executives
We also encourage your colleagues and you to come in a group to the conference and avail the best possible discounts on Registration and accommodation.
We believe your voice would be a critical addition to the Euro Biopharma 2017 stage.
Thank you for reading, and we look forward towards receiving your participation confirmation at the earliest convenience.
Conference Series has been instrumental in conducting international Biopharmaceuticals meetings for several years, and very excited to expand Europe, America and Asia Pacific continents. Previous meetings were held in major cities like San Francisco, Baltimore, with success the meetings again scheduled in continents. 4th European Biopharma Congress, is scheduled to be held during November 09-11, 2017; at Vienna, Austria.
Chris Chappell
Program Manager | Euro Biopharma
Kemp House,
152 City Road,
London EC1V 2NX
Direct:+1-800-216-6499
Email:eurobiopharma@pharmaceuticalconferences.org
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release 4th European Biopharma Congress here
News-ID: 553752 • Views: …
More Releases for Biopharma
Global Biopharma Outsourcing Market 2022 Future Set to Massive Growth | Major Pl …
The "Global Biopharma Outsourcing Market Analysis to 2030" is a particular and top to bottom analysis of the Biopharma Outsourcing industry with an emphasis on the worldwide market trend. The report expects to provide an overview of worldwide Biopharma Outsourcing market detailed market segmentation by service, organization mode, application and geography. The worldwide Biopharma Outsourcing market is predictable to witness high growth during the forecast period. The report gives key…
Biopharma Outsourcing Global Market Outlook - BioPharma Services, Lambda Therape …
The Biopharma Outsourcing Market Perspective, Comprehensive Analysis along with Major Segments and Forecast, 2020-2026. The Biopharma Outsourcing market report is a valuable source of data for business strategists. It provides the industry overview with market growth analysis with a historical & futuristic perspective for the following parameters; cost, revenue, demands, and supply data (as applicable). The report explores the current outlook in global and key regions from the perspective of…
Biopharma Outsourcing Market 2019: Top Key Players are Sartorius, Emcure Pharmac …
Biopharma Outsourcing Market 2019 Report analyses the industry status, size, share, trends, growth opportunity, competition landscape and forecast to 2025. This report also provides data on patterns, improvements, target business sectors, limits and advancements. Furthermore, this research report categorizes the market by companies, region, type and end-use industry.
Get Sample Copy of this Report@ - https://www.researchreportsworld.com/enquiry/request-sample/13899552
Global Biopharma Outsourcing market 2019 research provides a basic overview of the industry including definitions,…
Biopharma Outsourcing Market by Top players - Sartorius, Emcure Pharmaceuticals, …
The new report on the global Biopharma Outsourcing market provides key insights into the Biopharma Outsourcing market. The market report is ideal for customers looking to gain actionable insights into the market which can assist them in furthering their business. The global report provides a detailed analysis of all the parameters within the Biopharma Outsourcing market. The market report pegs the global Biopharma Outsourcing market at US$ XX million at…
Biopharma Outsourcing Market Future Analysis to 2023 |Sartorius, Emcure Pharmace …
According to the Biopharma Outsourcing Market report, the global market is expected to witness a relatively higher growth rate during the forecast period. This Biopharma Outsourcing Market Report cover strategic profiling of key players in the market, comprehensively analyzing their core competencies, and drawing a competitive landscape for the market. This study also analyzes the market status, market share, growth rate, future trends, market drivers, opportunities and challenges, risks and…
Biopharma Outsourcing 2018 Global Market SWOT Analysis and Opportunities To 2023 …
WiseGuyReports.Com Publish a New Market Research Report On –“ Biopharma Outsourcing 2018 Global Market SWOT Analysis and Opportunities To 2023 | Key Players : Sartorius, Emcure Pharmaceuticals, BioPharma Services, Baxter Healthcare, Keyrus Biopharma, Quintiles”.
Description:-
Biopharma outsourcing plays an important role in the growth of biopharmaceuticals market. The growth of this market is promising with rapidly expanding biosimilars base.
Scope of the Report:
This market encompasses various contract companies that provide clinical trials, drug…